CBEE Fall Seminar Series
Monday, Oct. 24, 2022
4:00 PM – 5:00 PM

Owen 106
Katherine A. Mirica

Katherine was born and raised in Ukraine and emigrated with her family to the United States as she was starting high school. She obtained her B.S. in Chemistry at Boston College, where she developed a passion for Materials Chemistry, working in the laboratory of Lawrence T. Scott. She earned her Ph.D. in Chemistry from Harvard University under the guidance of George M. Whitesides and completed her postdoctoral training with Timothy M. Swager at the Massachusetts Institute of Technology. Katherine began her independent scientific career as an Assistant Professor in the Department of
Chemistry at Dartmouth College in July 2015 and was promoted to Associate Professor with tenure in 2021. Her research interests span the topics of self-assembly, design and synthesis of multifunctional
framework materials, electroanalysis, energy, catalysis, and adhesion science.

“Molecular Engineering of Conductive Framework Materials for Chemical Sensing”
Molecular engineering of new materials holds promise for improving human health, safety,
efficiency, and quality of life. This presentation will describe strategies for molecular
engineering of conductive, stimuli-responsive, and molecularly precise materials. The
presentation will describe several approaches for design, synthesis, and device integration of
two-dimensional (2D) conductive metal–organic frameworks (MOFs) and covalent organic
frameworks (COFs) to create devices with promising utility in electroanalysis. An emphasis will
be placed on the fundamental understanding and molecular design of modular
structure–property relationships within this class of 2D materials. In summary, this
presentation will demonstrate how molecular-level features within solid state materials can be
used to tune their stimuli-responsive function.

Jim Clarke

Director of Quantum Hardware, Intel Labs

Presenting on:

From a Grain of Sand to a (Quantum) Bit of Information

Monday, Nov 21st, 2022 ● 4:00 – 4:50pm ● DEAR 118

Abstract

A large scale quantum computer could change the world.  Performing certain calculations in minutes that would take the largest supercomputer millions of years.  The impact to applications such as cryptography, chemistry, finance, etc would be huge. Today’s quantum processors are limited to 10’s of entangled quantum bits.   If you believe the hype, a commercially relevant system is just around the corner that can outperform our largest supercomputers for useful calculations.   The reality, however, is that we are still early in the race.    There are many unanswered fundamental questions.   At Intel, our approach is to rely on the continued evolution of Moore’s Law to build qubit arrays with a high degree of process control. Here, we present progress toward the realization of a 300mm Si/SiGe based spin qubit device in a production environment.  A spin qubit relies on the spin of a single electron in an external magnetic field to encode the two states of the qubit, where spin up vs down represent 0 vs 1.   Spin Qubits are compelling as their appearance and fabrication is similar to conventional CMOS transistors that drive the microelectronics industry.  At the same time, they are roughly one million time smaller than the superconducting qubits that are being pursued by other companies.  In addition, this talk will focus on a key bottleneck to moving beyond today’s few-qubit devices:  the interconnect scheme and control of a large quantum circuit.  Today’s qubits have personalities.  Individual control of each qubit is required.   A small quantum processor today has multiple RF and DC wires per qubit.   This is a brute force approach to wiring and will not scale to the millions of qubits needed for large applications.  At Intel, we have developed customized control chips, optimized for performance at low temperature, with a goal of simplifying wiring and replacing the racks and racks of discrete electrical components.

Bio

Jim Clarke is the director of the Quantum Hardware research group within Intel’s Components Research Organization. Jim launched Intel’s Quantum Computing effort in 2015, as well as a research partnership with QuTech (TU Delft and TNO). His group’s primary focus is to use Intel’s process expertise to develop scalable qubit arrays.  In 2018, Jim worked with industry leaders and the Intel policy group to influence the U.S. National Quantum Initiative Act.  Prior to his current role, Jim managed a group focused on interconnect research at advanced technology nodes as well as evaluating new materials and paradigms for interconnect performance. He has co-authored more than 100 papers and has over 50 patents.  Prior to joining Intel in 2001, Jim completed a B.S. in chemistry at Indiana University, a Ph.D. in physical chemistry at Harvard University and a post-doctoral fellowship in physical organic chemistry at ETH, Zürich.   He is a member of IEEE.

Dr. Nir Modiano (modiano@ohsu.edu) from OHSU, is looking to collaborate with a chemist or toxicologist on an effort to understand whether the therapeutic PPS may contribute to inflammatory bowel disease.

“Briefly, PPS is a sulfated polysaccharide that is used as a therapy for interstitial cystitis.  We have found that a few of our IBD patients on PPS improved after stopping the PPS.  In the 1990’s studies of high-dose PPS use for bladder cancer were dose-limited by proctitis, supporting the notion that it could be a causative agent in colitis.  We then noticed a number of patients on it developed multifocal dysplasia, requiring colectomy to prevent progression to malignancy.  Since the number of patients taking PPS is fairly small, we collaborated with Stanford and identified 30 patients with IBD who had been on PPS for >2 years (arbitrarily chosen because we did not want to include patients who had minimal exposure).  Of these, 1 in 3 developed multifocal dysplasia as of time of our study, which is a very high number.  We think this case series supports the hypothesis that PPS may increase the risk of both IBD and colonic dysplasia, though obviously, a small case series is not a definitive study.     

Of note, PPS may share similiarities in chemical structure with DSS, and both are sulfated polysaccharides, though we have not yet had a chemist or toxicologist weigh in on whether the similarities are likely to be relevant.  We’d be interested in gaining perspective from someone with relevant experience in toxicology to help us understand our observations and, perhaps, collaborate on research related to these findings.  One reason I find this so interesting is that it may offer insight into other environmental exposures that may be contributing to the rapid increase in IBD cases we are seeing in the western world, and perhaps, the increased rates of colorectal cancer at younger ages.”

Dear Oregon State Colleagues,

We are pleased to announce the launch of the Research Impact and Advancement Academy on Friday, October 21. This Academy is designed by the new Office for Research Advancement to bolster and enhance the ability for OSU researchers to successfully lead and compete for large collaborative proposals. It will provide a social learning structure where faculty can develop the knowledge, skills, practices, and relationships to successfully lead large transdisciplinary proposals, and execute and manage funded solutions-focused research programs.

In the inaugural year of the Academy, 20 Fellows have been selected in close cooperation with the Deans and Associate Deans for Research. They represent expertise across colleges and a wide range of the research strengths at OSU. The Fellows will enter the Academy for a two-year program starting out with a series of ten workshops for the first year. In these workshops, they will develop mindsets and frameworks for leading large transdisciplinary research efforts and will be provided the tools and practices of leading this type of work. During the Spring term, the Fellows will develop a multi-year plan and proposal for success and pitch for seed funds to pursue those plans. The Academy will be recurring with a new cohort of faculty every academic year.

Integrated into this first Academy cohort will be ten Valley Fellows concentrating on solutions to significant biohealth challenges. The biohealth sciences focuses on human health in a holistic manner, by identifying mechanisms and health risks, with emphasis on optimizing health through both prevention and treatment. Proposal development will be aiming for NIH and other funding opportunities focused on biohealth sciences. The Valley Fellows Program is funded through a generous grant from the Wayne and Gladys Valley Foundation.

Finally, the Office of Research Advancement is rolling out additional workshops and organizing several campus conversations. In total, seven Research Office Campus Conversations (ROCC) and two to three Research Office Lunch and Learn (ROLL) workshop series will be organized each academic year. Topics include ‘Demystifying USDA Funding’, ‘Going for Large Center/Facility Proposals’, ‘Integrating JEDI into Proposal Writing’ and ‘New-to-NIH’. In addition, the Research Office Advancement IGNITE series will bring university-wide communities together around broad research themes that are eminently growing in importance and strength at OSU. Topics this coming year include ‘Public Health and Climate Change’, ‘Water Resilience’ and ‘Renewable Clean Energy’.

Our offices are committed to supporting your success in accomplishing our research mission. Together, all of these new activities are in support of further advancing the research enterprise and scholarship at OSU while increasing the impact of our work in the arenas of both transdisciplinary research and scholarship and use-inspired research, two areas where OSU is extremely well positioned to excel and become leaders.

Sincerely,

Edward Feser

Provost and Executive Vice President

Irem Tumer

Vice President for Research

POSITION DESCRIPTION

Position            Specialist, Quality Control

Company          Vernal Biosciences

Location           Essex, Vermont

Website            www.vernal.bio

COMPANY BACKGROUND

Vernal Biosciences is an mRNA manufacturing and lipid nanoparticle formulation company that is transitioning its research-use-only business and technology to become a cGMP-compliant contract development and manufacturing organization (CDMO).  Vernal’s products are known within the industry to be high purity and useful to all known use cases for mRNA, including vaccines, gene editing and regulation, immuno-oncology, gene replacement therapy, and more.  Vernal’s planned growth, supported by Ampersand Capital and Dynamk Capital, includes a new 23,000 SF facility in Essex Vermont, to manufacture bulk clinical drug products.  Vernal’s investors have an outstanding track record of building successful CDMOs, as the principal investors in and operators of Brammer Bio (now part of ThermoFisher Patheon), CMC Biologics (now AGC Biologics), Arranta Bio, and Vibalogics (both now part of Recipharm).

Job Summary

The Specialist, Quality Control will be responsible for supporting Quality Control functions including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities. He or she partners with manufacturing sciences and technology (MSAT), quality assurance, and operations to support applicable aspects of CDMO work. This individual will also have growth opportunities to learn different facets of the business including manufacturing and different aspects of CQV deliverables.  This individual will also work with establishing the electronic laboratory information management system (LIMS).

Key Areas of Focus

  • Uses Vernal’s quality systems and programs to promote high-quality standards and continuous quality improvement.
  • Train and execute various QC tests, including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities
  • Support establishing and use of LIMS.  
  • Utilize the electronic quality management system (eQMS, Master Control) for writing, reviewing, and training on GMP documents and to document on-the-job training.
  • Ensures compliance with FDA Good Clinical Practice (GCP) and Good Manufacturing Practices (GMP), EU, and ICH guidelines and regulations with respect to job functions at Vernal.
  • Provides back-room support for health authority inspections and customer audits
  • Ensures documentation is compliant with Vernal SOPs, formats, and regulatory requirements (protocols, amendments, etc.)
  • Utilize Vernal’s eQMS and LIMS to ensure QC testing is properly executed.

Essential Duties and Responsibilities

  • Support quality policy, mission, and vision.
  • Execute various QC tests, including but not limited to incoming materials, in-process bulk drug substances, and final drug product release testing, environmental monitoring of cleanroom facilities
  • Support the development and documentation of QC tests under GMP guidelines and Good Documentation Practices.
  • Represent the Quality Control organization in internal discussions.

 

Professional Experience and Qualifications

  • Bachelor’s degree in a scientific or engineering discipline or equivalent experience required. 
  • 0-5 years in a role familiar with the quality control organization.  
  • GLP/GMP experience in a biotech, pharmaceutical or clinical research organization is beneficial
  • Demonstrated ability to participate in cross-functional teams.
  • Demonstrated ability to work independently, handle multiple tasks simultaneously, and escalate needs to meet critical timelines.
  • Experience or familiarity in quality control laboratory testing or environmental monitoring is a plus.
  • Basic knowledge of GCP, GLP, ICH guidelines, FDA guidelines, and other applicable regulatory requirements.
  • Excellent organizational, verbal, and written communication skills. 
  • Demonstrated ability to problem-solve and learn.

The Department of Chemistry and Chemical Biology at Northeastern University has multiple faculty openings in Boston. 

Tenure-track position in Antibiotic Resistance and Antimicrobials https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Open-Rank–Assistant-Associate-Professor—Antibiotic-Resistance-and-Antimicrobials–Chemistry-and-Chemical-Biology_R109460

Tenure-track position in Metabolism in Brain and Body Health https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Open-Rank–Assistant-Associate-Professor—Metabolism-in-Brain-and-Body-Health–Chemistry-and-Chemical-Biology_R109692-1

Tenure-track INVEST position, open research area, to give excellent candidates at the earliest stages of their careers the opportunity, resources, and support to establish innovative and impactful research careers. Postdoctoral research experience is not required. https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Assistant-Professor—INVEST-Program—College-of-Science_R107522

Tenure-track position in Experimental Biological Physics, possible joint appointment in Chemistry https://northeastern.wd1.myworkdayjobs.com/en-US/careers/job/Boston-MA-Main-Campus/Open-Rank–Assistant-Associate-Professor—Experimental-Biological-Physics_R109716

Biotechnology Teaching Professor (full time): The instructor will be responsible for teaching core biotechnology courses (Cell Culture Processes for Biopharmaceutical Production, Molecular Cell Biology for Biotech, and/or Protein Chemistry, Foundations in Biotechnology), and lead one of the defined program concentrations. https://northeastern.wd1.myworkdayjobs.com/en-US/careers/details/Assistant-Associate-Teaching-Professor—Biotechnology-Programs_R109414

OMSI Communication Fellowship Info Session: The College of Science will host a presentation & answer questions about the OSU-OMSI Spring Science Communication Fellows Program held on campus. The program is open to any faculty, postdocs, staff, or graduate students (STEM professionals) at OSU. Undergraduates engaged in research may be considered. Contact Andrew Haight, OMSI’s Director of Guest Engagement, at (503)797-4669 or ahaight@omsi.edu  for more information.

Join us on Oct. 26, noon – 1 p.m. in Kidder 128 Conference Room to learn more.

The annual Portland American Chemical Society High School and Undergraduate Poster Symposium and Career Fair will be special this year.  Aside from being the first in three years, it will also be concurrent with the quadrennial Pauling Symposium, which is also being hosted by the Portland Section.  The event will be held on Saturday (NOTE! Not the usual Sunday!) October 29, at the RLSB Building on the South Waterfront, from 11 AM-1 PM.  This year we are inviting the Puget Sound Section to join the Oregon and Portland sections, and we are opening it to grad students as well (although they will be in a separate category for prize purposes).  There will be no Career Fair this year.

All poster presenters are invited to attend the Pauling Symposium and Banquet free of charge.  Those wishing to do so should register for the Pauling Symposium Banquet separately.

I am writing to seek your help in getting this information to every undergraduate or high school student attending a school in the Portland or Oregon or Puget Sound ACS sections who did chemistry-related research during the past year.  No one knows this better than the faculty.  Please forward this to appropriate students; in addition to those who did research on campus, please try to remember those who did research somewhere else.  Company and national lab internships count, as long as the students are able to divulge their results, and researchers from other departments are also welcome, as long as there is some connection to chemistry.  The results need not be high impact—we understand that some projects do not work as expected, but one can still make good posters about them.  

There is no selection process for this event—any student registering may present.  Full information, including registration instructions, can be found at the following web site:  https://sites.google.com/site/portlandacsposters/home.  However, we do not want a bunch of no-shows—registration should constitute a good-faith commitment to attend and present.

Deadline for registration is October 15.  We need some lead time to prepare the booklet. 

OSU faculty and graduate student researchers are invited to join the OSU Advantage office Oct. 6 (10 a.m. and 2 p.m.) for a one-hour virtual event (offered once in the morning and once in the afternoon) that will describe funding and training opportunities that support innovation and entrepreneurship at the federal, state and OSU levels. At this event, you will also learn how to apply for a special $5,000 Innovation Award available from OSU Advantage. Register here for a Zoom link: https://forms.gle/TkqQC14sa6UbQ8rw9.

Our team is comprised of creative, highly-skilled innovators who are engaged in research and technology development. This position is for a senior team member who will be involved with chemically upcycling wastes or undervalued feedstocks to produce new sustainable materials for the asphalt industry.
The focus of the Lead Scientist will include:
• Generating new ideas and collaborating with the research team to expand research capabilities
• Investigating new approaches for chemically upcycling wastes or undervalued feedstocks
• Propose creative low-cost chemistries, experimental design and implementation
• Chemical characterization of products through multiple methods, reaction mechanism investigations, and materials balance determination to help guide techno economic analysis and environmental impacts
• Review literature, write reports, assisting in writing proposals, and authoring peer-reviewed publications (when appropriate)
• Organizing and directing project activities and coordinating the efforts of a project team
• Supervising, interpreting and reviewing the applicability and accuracy of data and providing feedback to clients and project staff
• Planning, designing, coordinating, and controlling the progress of project work and communicating the progress to clients and senior management
The ideal candidate will have a PhD in Chemistry, or closely related field, with a strong background in synthetic organic chemistry or polymer chemistry. Experience in petroleum, coal, biomass, green chemistry, thermochemical/chemical conversion (liquefaction or extraction), asphalt or with producing asphalt products (or asphalt formation) is desirable.
Individuals will thrive in this position if they have a passion for innovation and problem solving, a desire to engage in a team-oriented culture, are detail-oriented, and possess strong verbal and written communication skills. Team members who excel in this position will have opportunities for future growth.
Starting Salary Range: $80,000 to $85,000 per year
We offer a comprehensive benefit package, including generous paid time off, flexible schedules, and tuition waivers for one free class at the University of Wyoming each semester. Our package includes a retirement plan (with an 8% employer contribution after one year and options to contribute to a supplemental plan), insurance (medical, dental, vision, and life) and an employee assistance program.
Submit resume and cover letter to Michelle Holmes, Human Resources Manager, by email at mholmes1@uwyo.edu. The position is open until filled.
WRI is an Equal Opportunity Employer.